What is the interpretation of a Forced Vital Capacity (FVC) of 32 percent, a Forced Expiratory Volume in one second to Forced Vital Capacity (FEV1/FVC) ratio of 80 percent, and a Forced Expiratory Volume in one second (FEV1) of 38 percent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The pulmonary function test results indicate a restrictive pattern, characterized by a significantly reduced FVC of 32% and a normal to elevated FEV1/FVC ratio of 80%, suggesting a condition that limits lung expansion. With an FVC of 32% of predicted value, there is a significant reduction in lung volume, and the FEV1 (Forced Expiratory Volume in 1 second) of 38% of predicted value is also reduced, but proportionally to the FVC reduction 1. This pattern is consistent with restrictive lung disease, rather than obstructive disease, as the FEV1/FVC ratio is normal or elevated, which is characteristic of restrictive lung disease 1.

The patient's symptoms and test results suggest a condition that limits lung expansion, such as:

  • Interstitial lung disease
  • Chest wall disorders
  • Neuromuscular weakness
  • Pleural disease Further evaluation, including chest imaging (high-resolution CT scan), complete clinical assessment, and possibly additional tests like diffusion capacity (DLCO), is necessary to determine the specific cause of restriction 1.

Treatment should focus on addressing the underlying etiology, and may include corticosteroids for inflammatory conditions, immunosuppressants for autoimmune disorders, or supportive care with supplemental oxygen if hypoxemia is present. Pulmonary rehabilitation may also be beneficial to optimize remaining lung function and improve quality of life 1. It is essential to prioritize the patient's morbidity, mortality, and quality of life when developing a treatment plan, and to consider the most recent and highest-quality evidence available 1.

From the Research

Interpretation of Pulmonary Function Test Results

The given results are FVC 32, FEV1/FVC 80, and FEV 38. To interpret these results, we need to understand what each parameter represents:

  • FVC (Forced Vital Capacity) is the total amount of air that can be exhaled from the lungs after a maximum inhalation.
  • FEV1 (Forced Expiratory Volume in 1 second) is the amount of air that can be exhaled in the first second of a forced exhalation.
  • FEV1/FVC is the ratio of FEV1 to FVC, which helps to diagnose obstructive and restrictive lung diseases.

Analysis of Results

Based on the given values:

  • The FEV1/FVC ratio is 80, which is greater than 70, indicating that the patient does not have a significant obstructive lung disease like COPD, as a post-bronchodilator FEV1/FVC < 0.70 confirms the presence of persistent airflow limitation and the diagnosis of COPD 2.
  • The FVC value is 32, which is lower than normal, suggesting a restrictive lung disease. Interstitial lung diseases (ILDs) are functionally characterized by a restrictive ventilatory defect due to a reduced distensibility of the lung parenchyma 3.
  • The FEV value is 38, which is also lower than normal, further supporting the presence of a restrictive lung disease.

Possible Diagnosis

Considering the low FVC and FEV values, along with a normal FEV1/FVC ratio, the patient may have a restrictive lung disease, such as an interstitial lung disease (ILD). Pulmonary function tests have been widely accepted and utilized in the management of interstitial lung diseases, and can aid in defining the prognosis of ILDs and in referring patients for lung transplantation 3, 4. However, the diagnosis of ILD should be confirmed by other clinical and radiological findings, as pulmonary function tests alone are not specific for ILD 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Diagnosis and examination for COPD. Pulmonary function tests].

Nihon rinsho. Japanese journal of clinical medicine, 2016

Research

Pulmonary function testing in interstitial lung diseases.

Respiration; international review of thoracic diseases, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.